Internal Medicine, Nephrology · Kearney, NE
NPI
1336122597
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3219 Central Ave, Suite 200
Kearney, NE, 68847
Phone (308) 865-2370
Groups this clinician bills Medicare through
Medicare paid, 2024
$191K
9,199 services
Medicare patients, 2024
813
Average age 75
Drug cost, 2024
$1.2M
4,037 prescriptions
Company payments, 2025
$429
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Imtiaz Islam was code 90970 (esrd related services (not dialysis)), 789 times for 31 patients. In total Imtiaz Islam billed 9,199 services in 31 codes, and Medicare paid $191K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90970 ESRD Related Services (not dialysis) | Office | 789 | 31 | $6.91 | $5,449 |
| 99214 Office E&M - Established | Office | 372 | 213 | $85.51 | $32K |
| 36415 Venipuncture Blood Collection | Office | 354 | 293 | $6.86 | $2,428 |
| 99232 Hospital E&M - Subsequent | Facility | 307 | 108 | $57.03 | $18K |
| 99214 Office E&M - Established | Facility | 297 | 176 | $64.03 | $19K |
| 90960 ESRD Related Services (not dialysis) | Office | 197 | 33 | $254.03 | $50K |
| 90966 ESRD Related Services (not dialysis) | Office | 129 | 20 | $214.52 | $28K |
| 99204 Office E&M - New | Office | 69 | 69 | $110.87 | $7,650 |
| 99223 Hospital E&M - Initial | Facility | 56 | 53 | $126.21 | $7,068 |
| 90935 Hemodialysis | Facility | 47 | 28 | $49.49 | $2,326 |
| 99213 Office E&M - Established | Office | 35 | 34 | $56.94 | $1,993 |
| 90961 ESRD Related Services (not dialysis) | Office | 27 | 16 | $203.26 | $5,488 |
| 99213 Office E&M - Established | Facility | 25 | 22 | $36.41 | $910 |
| 99233 Hospital E&M - Subsequent | Facility | 22 | 19 | $82.49 | $1,815 |
| 99204 Office E&M - New | Facility | 15 | 15 | $82.67 | $1,240 |
By year: 2022 $271K for 5,532 services; 2023 $235K for 5,200 services; 2024 $191K for 9,199 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 354 | 293 | $6.86 | $2,428 |
Medicare prescription drug claims, 2024
In 2024, the drug Imtiaz Islam prescribed most often to Medicare patients was Lisinopril, with 275 prescriptions and refills. In total Imtiaz Islam wrote 4,037 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lisinopril Generic | 275 | 416 | 72 | $1,202 |
| Telmisartan Generic | 263 | 403 | 52 | $8,800 |
| Amlodipine Besylate Generic | 242 | 361 | 56 | $1,631 |
| Torsemide Generic | 231 | 305 | 57 | $4,003 |
| Potassium Chloride Generic | 216 | 274 | 47 | $5,435 |
| Losartan Potassium Generic | 209 | 327 | 53 | $2,998 |
| Sevelamer Carbonate Generic | 195 | 244 | 45 | $32K |
| Calcitriol Generic | 191 | 259 | 37 | $1,636 |
| Furosemide Generic | 160 | 209 | 35 | $644 |
| Jardiance Empagliflozin | 152 | 181 | 26 | $105K |
| Farxiga Dapagliflozin Propanediol | 151 | 191 | 30 | $101K |
| Chlorthalidone Generic | 141 | 237 | 37 | $2,031 |
| Midodrine Hcl Generic | 106 | 139 | 19 | $5,025 |
| Carvedilol Generic | 95 | 125 | 17 | $735 |
| Bumetanide Generic | 89 | 105 | 21 | $2,756 |
Brand drugs: 616 claims; generic drugs: 3,421 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Imtiaz Islam $429 ($429 in general payments such as food, travel and fees) from 11 companies. The largest payer was Amgen Inc. with $137.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 14 | $137 |
| Travere Therapeutics, Inc. TVTX | 6 | $91.79 |
| Fresenius USA Marketing, Inc. | 2 | $33.44 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $32.74 |
| Medtronic, Inc. MDT | 1 | $27.29 |
| Ardelyx, Inc. ARDX | 1 | $20.69 |
| Calliditas Therapeutics US Inc. | 1 | $20.66 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $17.89 |
| GlaxoSmithKline, LLC. GSK | 1 | $17.6 |
| Vifor Pharma, Inc. | 1 | $15.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.